CRAI
CRA International, Inc.
CRAI's fundamentals are mixed, but it looks expensive: trading at 25x earnings, above its usual 20x. Analysts expect earnings growth.
EOSE
Eos Energy Enterprises, Inc.
There isn't enough reported data to score EOSE yet.
CRAI Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Under pressure | |
| Strong |
CRAI's revenue, profitability and balance sheet are currently healthy, but its cash flow is under pressure.
EOSE Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
EOSE's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
CRAI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $130 | -35% |
| Fair | 20x | $162 | -19% |
| Forward | 22x | $199 | โ |
| Current | 25x | $199 | โ |
| Expensive | 26x | $204 | +2.6% |
Historical ranges are pointers, not guarantees.
CRAI's PE is in its expensive range at 25x. If earnings grow as analysts expect, today's price would be 22x next year's earnings, in its fair range.
EOSE PE Valuation
EOSE has no meaningful PE right now: it lost money over the past year.
CRAI Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for CRAI, with profitability holding steady.
EOSE Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect EOSE's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
CRAI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.25 | +16% |
| Q3 2026 | $7.99 | -4% |
| Q2 2026 | $7.52 | -9% |
| Q1 2026 | $7.21 | -2.7% |
| Q4 2025 | $8.14 | +21% |
| Q3 2025 | $8.32 | +35% |
| Q2 2025 | $8.26 | +45% |
| Q1 2025 | $7.41 | +21% |
| Q4 2024 | $6.74 | +25% |
CRAI has the stronger earnings trend. Trailing diluted EPS is down 4% for CRAI versus EOSE down 224%.
EOSE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2023 | -$2.69 | +$0.85 |
| Q2 2023 | -$3.76 | -$1.00 |
| Q1 2023 | -$3.65 | -$0.86 |
| Q4 2022 | -$3.68 | -$1.32 |
| Q3 2022 | -$3.54 | +$5.19 |
EOSE is still losing money, but less than at its worst: $4.55 per share over the past year, against $8.73 at its worst in late 2021.
CRAI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $214.9M | +16% |
| Q2 2026 | $210.8M | +13% |
| Q1 2026 | $201M | +11% |
| Q4 2025 | $197M | +12% |
| Q3 2025 | $185.9M | +11% |
| Q2 2025 | $186.9M | +9% |
| Q1 2025 | $181.9M | +5.9% |
| Q4 2024 | $176.4M | +9.2% |
CRAI's revenue has grown year over year for 12 quarters in a row: $215M last quarter, up 16% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 11% | +1.9 points |
| Q2 2026 | 11% | +0.6 points |
| Q1 2026 | 9% | -5.1 points |
| Q4 2025 | 10% | -1.7 points |
| Q3 2025 | 9.3% | -1.7 points |
| Q2 2025 | 11% | +4 points |
| Q1 2025 | 14% | +2.6 points |
| Q4 2024 | 12% | +1.6 points |
CRAI has the edge over EOSE on profitability, with a higher operating margin.
EOSE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $82.7M | +171% |
| Q2 2026 | $68.8M | +351% |
| Q1 2026 | $57M | +445% |
| Q4 2025 | $58M | +700% |
| Q3 2025 | $30.5M | +3473% |
| Q2 2025 | $15.2M | +1597% |
| Q1 2025 | $10.5M | +58% |
| Q4 2024 | $7.3M | +9.7% |
EOSE has the edge over CRAI on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -96% | +105 points |
| Q2 2026 | -122% | +297 points |
| Q1 2026 | -139% | +367 points |
| Q4 2025 | -140% | +573 points |
| Q3 2025 | -201% | +6044 points |
| Q2 2025 | -419% | +2815 points |
| Q1 2025 | -506% | +117 points |
| Q4 2024 | -713% | -74 points |
EOSE's operating margin was โ96% last quarter, up 105 points from the same quarter a year ago, near the top of its range since 2019.
CRAI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $73.2M | +104% |
| Q2 2026 | -$6.1M | -230% |
| Q1 2026 | -$116.5M | -$35.6M |
| Q4 2025 | $59M | -14% |
| Q3 2025 | $35.9M | +26% |
| Q2 2025 | $4.7M | +$5.2M |
| Q1 2025 | -$81M | -$17.2M |
| Q4 2024 | $68.8M | +15% |
CRAI has the edge over EOSE on cash generation, producing positive trailing cash flow while its opponent burns cash.
EOSE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$105.1M | -$22.4M |
| Q2 2026 | -$107.4M | -$34.3M |
| Q1 2026 | -$154.8M | -$121M |
| Q4 2025 | -$75.2M | -$19.5M |
| Q3 2025 | -$82.7M | -$28.5M |
| Q2 2025 | -$73.2M | -$40.6M |
| Q1 2025 | -$33.8M | +$10.7M |
| Q4 2024 | -$55.8M | -$10.2M |
EOSE has burned cash in almost every quarter: โ$443M over the past year, against โ$246M the year before.
CRAI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 2.1x | Moderate |
| Q1 2026 | 1.8x | Healthy |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.7x | Very low |
| Q2 2025 | 1.0x | Healthy |
| Q1 2025 | 0.7x | Very low |
| Q4 2024 | -0.3x | Net Cash |
CRAI's net debt is less than a year of its operating earnings (EBITDA).
EOSE Net Leverage
EOSE's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CRAI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 64.2 | Neutral |
| Stochastic | 74.6 | Neutral |
CRAI's weekly RSI is 64 (neutral) and its Stochastic is 75 (neutral).
EOSE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.5 | Neutral |
| Stochastic | 7.4 | Oversold |
EOSE's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
CRAI PE vs Industrials Sector
| Metric | CRAI | Sector median | Relative |
|---|---|---|---|
| PE | 25x | 24x | 3.8% above |
| PE % | 79 | 58 | 21 pts above |
CRAI is trading at 25x earnings, in line with the Industrials sector's median of 24x.
EOSE PE vs Industrials Sector
EOSE has no meaningful PE right now: it lost money over the past year.
CRAI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $185.1 | 7.7% above |
| 20 week MA | $174.8 | 14% above |
| 50 week MA | $171.8 | 16% above |
| 100 week MA | $178.3 | 12% above |
| 200 week MA | $154.8 | 29% above |
CRAI has the edge over EOSE on trend strength, trading above more of its moving averages.
EOSE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.24 | 19% below |
| 20 week MA | $3.28 | 45% below |
| 50 week MA | $7.01 | 74% below |
| 100 week MA | $7.10 | 75% below |
| 200 week MA | $4.53 | 60% below |
EOSE is in a downtrend: it's below all five of its weekly moving averages, and 60% below its 200-week average.
CRAI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $53.6 | $50.5 | -5.7% |
| 2021 | $50.5 | $92.3 | +83% |
| 2022 | $92.3 | $120.0 | +30% |
| 2023 | $120.0 | $98.9 | -18% |
| 2024 | $98.9 | $186.8 | +89% |
| 2025 | $186.8 | $206.2 | +10% |
| 2026 YTD | $206.2 | $199.3 | -3.4% |
CRAI has the edge over EOSE on returns for 2026, with the stronger performance.
EOSE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.72 | $19.2 | +98% |
| 2021 | $19.2 | $8.57 | -55% |
| 2022 | $8.57 | $1.08 | -87% |
| 2023 | $1.08 | $1.09 | +0.9% |
| 2024 | $1.09 | $5.17 | +374% |
| 2025 | $5.17 | $11.9 | +129% |
| 2026 YTD | $11.9 | $1.81 | -85% |
EOSE's yearly returns have swung widely, from +374% in 2024 to โ87% in 2022. It's down 85% so far in 2026.